BUZZ-Street View: Smoke-free product growth keeps Philip Morris on a high

Philip Morris International Inc.

Philip Morris International Inc.

PM

0.00

Philip Morris International PM.N beat Q2 earnings estimates on Wednesday and said it would ramp up investment in its smoke-free product, Zyn nicotine pouches, as competition intensifies in the fast-growing category

BETTING BIG ON SMOKE-FREE MOMENTUM

** BofA Global Research ("buy," PT: $194.30) says PM getting its smoke-free product ZYN's growth back on track is likely to be the key factor driving co's H2 share performance

** Morgan Stanley ("overweight," PT: $200) says underlying growth in smoke-free products, like ZYN, still looks strong, and co is spending wisely to fuel future growth

** Stifel ("buy," PT: $205) says co's robust smoke-free product business should support long-term growth

** Needham ("buy," PT: $215) says PM's strong sales in both cigarettes and smoke-free products continue to let it keep investing in growth without hurting its financial targets, "which is a clear competitive advantage"


This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.